STXS: stereotaxis.com Expected earnings per share growth for next year
The projected growth rate of net income per share reflects financial pressure stemming from R&D expenses and dwindling reserves. Meanwhile, Stereotaxis, Inc. (STXS) is recognized as the global benchmark in cardiac surgical robotics, ensuring exceptional procedural safety. The 27.80 mark serves as a key metric, confirming high margins driven by clinic dependence on unique consumables for magnetic systems.
Analytical breakdowns for stereotaxis.com (STXS)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Stereotaxis, Inc.|STXS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Stereotaxis|STXS - Company Total Debt Obligations|Debts to Book Capitalization Stereotaxis|STXS - Company Long-Term Liabilities|Company Short-Term Debts Stereotaxis|Quick Liquidity stereotaxis.com
- net income and valuation ratios data:
STXS - Company Net Income|Future Profit Stereotaxis, Inc.|STXS - Company Value to Net Income|Forward P/E Multiple Stereotaxis, Inc.|STXS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis|STXS - Operating profit before depreciation charges|Net earnings per share for the last 12 months Stereotaxis|STXS - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth stereotaxis.com|STXS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Stereotaxis, Inc.
Initial company analysis:Stereotaxis Corp, STXS
Unique patents in robotic cardiology and high switching costs provide Stereotaxis, Inc. (STXS) with resilience against pricing pressure. This metric measures the expected growth rate of earnings per share, reflecting the business's ability to generate income in a high-interest-rate environment. For the investor, this trend serves as an indicator of model maturity and the risk of capital stagnation. Evaluate the forward-looking EPS growth vector to determine the company's expansion potential.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year Establishment Labs Inc ESTA|Earnings growth forecast for next year BBNX (Beta Bionics Inc)|Earnings growth forecast for next year iradimed.com IRMD|EMBC - Net earnings per share growth forecast for next year|TNDM: Net earnings per share growth forecast for next year|AXGN (Axogen Corp) - Expected earnings per share growth for next year|SI-BONE Medical - Expected earnings per share trend next year|OFIX (Orthofix Medical Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year bioventus.com BVS|Net earnings per share growth forecast for next year OrthoPediatrics Corp. (KIDS)|Treace Medical Concepts Inc (TMCI) - Net earnings per one share growth forecast for next year|Strata Critical Medical Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year Carlsmed Medical CARL|RxSight, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ClearPoint Neuro, Inc. CLPT|Neuronetics (STIM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SGHT (Sight Sciences Inc.)|Net earnings per share growth forecast for next year Orchestra BioMed, Inc.|Expected earnings per share growth for next year Anika (ANIK)|Earnings growth forecast for next year NSPR|ZJYL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Vivani Medical VANI|XTNT: Projected earnings per share growth rate for next year|NMTC: Expected earnings per share growth for next year|Modular Medical - Projected earnings per share increase next year|Myomo, Inc. (MYO) - Net earnings per share growth forecast for next year|COCH - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year VVOS|NVNO (enVVeno Medical Corporation) - Projected earnings per share increase next year|Earnings growth forecast for next year SINT|TNON - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year ReWalk Robotics Ltd. LFWD|Expected earnings per share trend next year AMIX|INVO Fertility - Earnings growth forecast for next year|Expected net earnings per share growth next year Bone Biologics Corp.|Axonics Modulation Technologies (AXNX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Biolase Inc. (BIOL)|Expected earnings per share growth for next year DYNT|FNA (Paragon 28 Corp) - Projected earnings per share increase next year|Earnings growth forecast for next year INVO
